GASTROINTESTINAL MUCOSAL NECROSIS

This adverse event was reported 145 times

These drugs are most commonly taken by patients reporting GASTROINTESTINAL MUCOSAL NECROSIS:

# Drug Count
0 DOXYCYCLINE HYCLATE 56
1 DOXYCYCLINE 55
2 DOXYCLYCLINE HYCLATE 14
3 METFORMIN 12
4 CAPECITABINE 11
5 METFORMIN ER 500 MG 11
6 METFORMIN ER 750 MG 11
7 OMEPRAZOLE MAGNESIUM 10
8 OMEPRAZOLE 9
9 OXALIPLATIN 9
See all common drugs associated with GASTROINTESTINAL MUCOSAL NECROSIS

GASTROINTESTINAL MUCOSAL NECROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CEFUROXIME SODIUM 1 0.0008
1 DOXYCYCLINE HYCLATE 56 0.0008
2 DOXYCLYCLINE HYCLATE 14 0.0008
3 DOXYCYCLINE 55 0.0008
4 POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE 1 0.0008
5 TALIMOGENE LAHERPAREPVEC 1 0.0006
6 ACITRETIN 3 0.0006
7 AMPHETAMINE SULFATE TABLETS 1 0.0006
8 TERBUTALINE SULFATE 1 0.0005
9 EDOXABAN TOSYLATE 3 0.0004
See all drugs enriched for association with GASTROINTESTINAL MUCOSAL NECROSIS

GASTROINTESTINAL MUCOSAL NECROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tetracycline-class Drug [EPC] 55 0.0008
1 Calcitonin [EPC] 1 0.0003
2 Cannabinoid [EPC] 1 0.0001
3 Echinocandin Antifungal [EPC] 1 0.0001
4 Cephalosporin Antibacterial [EPC] 1 0.0001
5 Sigma-1 Agonist [EPC] 1 0.0001
6 Chloride Channel Activator [EPC] 1 0.0001
7 Bile Acid [EPC] 2 0.0001
8 Interleukin-17A Antagonist [EPC] 3 0.0001
9 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
See all drug classes enriched for association with GASTROINTESTINAL MUCOSAL NECROSIS